3 ms·
> I just can’t understand why it is like that. My guess is because phage treatments are difficult or impossible to patent, and therefore unattractive to pharma
by thayne 8y ago
> I just can’t understand why it is like that.
My guess is because phage treatments are difficult or impossible to patent, and therefore unattractive to pharmaceutical companies. And pharmaceutical companies are incentivized to push their own treatments on doctors and hospitals.
- whytaka 8y agoI can suppose that economic incentives don’t align for its availability in the field but it doesn’t account for the ignorance of the practitioners. Bacteriophages are almost always one of the first things mentioned when the inevitable futility of antibiotics is discussed.